Search results
OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoOPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript May 7, 2024 OPKO Health, Inc. misses...
Earnings call: Arcturus Therapeutics reports progress & Q1 losses
Investing.com· 2 days agoArcturus Therapeutics (NASDAQ: ARCT ) has announced during their First Quarter 2024 Earnings Call...
SIGA Technologies, Inc. (NASDAQ:SIGA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoSIGA Technologies, Inc. (NASDAQ:SIGA) Q1 2024 Earnings Call Transcript May 7, 2024 SIGA...
T2 Biosystems Inc (TTOO) Q1 2024 Earnings Call Transcript Highli
Guru Focus· 5 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. T2 Biosystems Inc (TTOO, Financial) achieved a 25% year-over-year growth in sepsis product ...
T2 Biosystems Inc (TTOO) Q1 2024 Earnings Call Transcript Highlights: Revenue Growth Amidst ...
GuruFocus.com via Yahoo Finance· 4 days agoAnd at the time we decide to pursue FDA 5-10K clearance, we'll be ready. Q: Let me ask another one for have off. The on. Barda is hasn't been in the model for for a couple ...
A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
Digital Journal· 3 days agoSHELTON, CT / ACCESSWIRE / May 8, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that the ultra-broad antiviral ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 18 hours agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
T2 Biosystems Inks Middle East Distribution, Lyme Disease Testing Deals as Q1 Revenues Dip 1 Percent
GenomeWeb News· 4 days agoT2 Biosystems reported after the close of the market on Monday that its first quarter revenues declined approximately 1 percent year over year, although product revenues were up 24 percent.
Soligenix to Present at Upcoming Conferences
FOX 23 News Albany· 5 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...